Outbound Relationships |
Type |
Target |
Active |
Characteristic |
Refinability |
Group |
Values |
bupivacainhydrochlorid 7,5 mg/glucose 82,5 mg injektionsvæske, opløsning, hætteglas |
Is a |
Product containing bupivacaine (medicinal product) |
false |
Inferred relationship |
Some |
|
|
bupivacainhydrochlorid 7,5 mg/glucose 82,5 mg injektionsvæske, opløsning, hætteglas |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
Bupivacaine (substance) |
false |
Inferred relationship |
Some |
|
|
bupivacainhydrochlorid 7,5 mg/glucose 82,5 mg injektionsvæske, opløsning, hætteglas |
Is a |
Bupivacaine + dextrose |
false |
Inferred relationship |
Some |
|
|
bupivacainhydrochlorid 7,5 mg/glucose 82,5 mg injektionsvæske, opløsning, hætteglas |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
Caloric agent (substance) |
false |
Inferred relationship |
Some |
|
|
bupivacainhydrochlorid 7,5 mg/glucose 82,5 mg injektionsvæske, opløsning, hætteglas |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
Dextrose |
false |
Inferred relationship |
Some |
|
|
bupivacainhydrochlorid 7,5 mg/glucose 82,5 mg injektionsvæske, opløsning, hætteglas |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
Carbohydrate |
false |
Inferred relationship |
Some |
|
|
bupivacainhydrochlorid 7,5 mg/glucose 82,5 mg injektionsvæske, opløsning, hætteglas |
Is a |
bupivacain + glucose |
false |
Inferred relationship |
Some |
|
|
bupivacainhydrochlorid 7,5 mg/glucose 82,5 mg injektionsvæske, opløsning, hætteglas |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
Glucose |
false |
Inferred relationship |
Some |
|
|
bupivacainhydrochlorid 7,5 mg/glucose 82,5 mg injektionsvæske, opløsning, hætteglas |
Has manufactured dose form |
injektionsvæske |
false |
Inferred relationship |
Some |
|
|
bupivacainhydrochlorid 7,5 mg/glucose 82,5 mg injektionsvæske, opløsning, hætteglas |
Is a |
Glucose-containing product in parenteral dose form |
false |
Inferred relationship |
Some |
|
|
bupivacainhydrochlorid 7,5 mg/glucose 82,5 mg injektionsvæske, opløsning, hætteglas |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
Bupivacaine hydrochloride |
false |
Inferred relationship |
Some |
|
|
bupivacainhydrochlorid 7,5 mg/glucose 82,5 mg injektionsvæske, opløsning, hætteglas |
Has manufactured dose form |
Solution for injection |
false |
Inferred relationship |
Some |
|
|
bupivacainhydrochlorid 7,5 mg/glucose 82,5 mg injektionsvæske, opløsning, hætteglas |
Is a |
Product containing bupivacaine in parenteral dose form (medicinal product form) |
false |
Inferred relationship |
Some |
|
|
bupivacainhydrochlorid 7,5 mg/glucose 82,5 mg injektionsvæske, opløsning, hætteglas |
Is a |
TEMPORARY parent for CDs that are not updated |
false |
Inferred relationship |
Some |
|
|